Immunomic Therapeutics' Grant

Immunomic Therapeutics raised a round of funding on January 08, 2007. Investors include Maryland Technology Development Corporation.

Immunomic Therapeutics (ITI) is a clinical stage biotechnology company developing next generation vaccines based on LAMP Technology. The company's LAMP-vax platform increases the effectiveness of the …

Articles about Immunomic Therapeutics' Grant: